Raymond James & Associates Novo Nordisk A S Transaction History

Raymond James & Associates

$161 Billion
Q3 2024

A detailed history of Raymond James & Associates transactions in Novo Nordisk A S stock. As of the latest transaction made, Raymond James & Associates holds 3,526,821 shares of NVO stock, worth $320 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares

3,526,821

Previous 3,507,198 0.56%

Holding current value

$320 Million

Previous $501 Million 16.12%

% of portfolio

0.26%

Previous 0.33%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 18, 2024	BUY	$119.07 - $145.42 $2.34 Million - $2.85 Million	19,623 Added 0.56%	3,526,821 $420 Million
Q2 2024 Jul 19, 2024	BUY	$122.71 - $146.91 $44.6 Million - $53.4 Million	363,467 Added 11.56%	3,507,198 $501 Million
Q1 2024 Apr 22, 2024	BUY	$102.11 - $135.92 $35.1 Million - $46.8 Million	344,049 Added 12.29%	3,143,731 $404 Million
Q4 2023 Jan 16, 2024	BUY	$87.78 - $105.45 $11.3 Million - $13.6 Million	129,140 Added 4.84%	2,799,682 $290 Million
Q3 2023 Oct 24, 2023	BUY	$90.94 - $199.54 $121 Million - $265 Million	1,327,556 Added 98.85%	2,670,542 $243 Million
Q2 2023 Jul 25, 2023	SELL	$155.98 - $172.65 $17.1 Million - $19 Million	-109,941 Reduced 7.57%	1,342,986 $217 Million
Q1 2023 Apr 14, 2023	BUY	$132.34 - $159.14 $9.31 Million - $11.2 Million	70,370 Added 5.09%	1,452,927 $231 Million
Q4 2022 Feb 08, 2023	BUY	$102.55 - $135.33 $1.21 Million - $1.6 Million	11,832 Added 0.86%	1,382,557 $187 Million
Q3 2022 Oct 25, 2022	SELL	$95.28 - $116.93 $2.12 Million - $2.6 Million	-22,250 Reduced 1.6%	1,370,725 $137 Million
Q2 2022 Aug 12, 2022	BUY	$103.24 - $121.81 $2.48 Million - $2.92 Million	23,986 Added 1.75%	1,392,975 $155 Million
Q1 2022 May 11, 2022	BUY	$93.1 - $112.54 $1.6 Million - $1.93 Million	17,166 Added 1.27%	1,368,989 $152 Million
Q4 2021 Feb 08, 2022	SELL	$95.88 - $117.08 $1.85 Million - $2.26 Million	-19,308 Reduced 1.41%	1,351,823 $151 Million
Q3 2021 Nov 02, 2021	BUY	$84.42 - $106.62 $3.12 Million - $3.95 Million	37,008 Added 2.77%	1,371,131 $132 Million
Q2 2021 Aug 11, 2021	BUY	$67.66 - $84.76 $14.8 Million - $18.5 Million	218,768 Added 19.61%	1,334,123 $112 Million
Q1 2021 May 14, 2021	BUY	$67.06 - $75.82 $5.02 Million - $5.68 Million	74,861 Added 7.19%	1,115,355 $75.2 Million
Q4 2020 Feb 12, 2021	SELL	$63.89 - $73.8 $5.74 Million - $6.63 Million	-89,840 Reduced 7.95%	1,040,494 $72.7 Million
Q3 2020 Nov 04, 2020	SELL	$63.69 - $70.22 $1.21 Million - $1.34 Million	-19,015 Reduced 1.65%	1,130,334 $78.5 Million
Q2 2020 Jul 28, 2020	SELL	$58.54 - $67.94 $9.75 Million - $11.3 Million	-166,611 Reduced 12.66%	1,149,349 $75.3 Million
Q1 2020 Apr 21, 2020	BUY	$49.46 - $64.78 $5.09 Million - $6.66 Million	102,849 Added 8.48%	1,315,960 $79.2 Million
Q4 2019 Feb 12, 2020	BUY	$49.86 - $58.26 $94,534 - $110,460	1,896 Added 0.16%	1,213,111 $70.2 Million
Q3 2019 Nov 07, 2019	BUY	$47.54 - $53.43 $906,825 - $1.02 Million	19,075 Added 1.6%	1,211,215 $62.6 Million
Q2 2019 Aug 06, 2019	BUY	$46.79 - $52.47 $843,857 - $946,296	18,035 Added 1.54%	1,192,140 $60.8 Million
Q1 2019 May 06, 2019	BUY	$46.36 - $52.63 $24.8 Million - $28.2 Million	535,302 Added 83.8%	1,174,105 $61.4 Million
Q4 2018 Feb 11, 2019	SELL	$41.54 - $47.25 $967,009 - $1.1 Million	-23,279 Reduced 3.52%	638,803 $29.4 Million
Q3 2018 Nov 14, 2018	BUY	$46.76 - $51.24 $576,363 - $631,584	12,326 Added 1.9%	662,082 $31.2 Million
Q2 2018 Aug 14, 2018	BUY	$44.29 - $50.42 $1.42 Million - $1.62 Million	32,152 Added 5.21%	649,756 $30 Million
Q1 2018 May 14, 2018	BUY	$48.49 - $58.14 $2.52 Million - $3.03 Million	52,049 Added 9.2%	617,604 $30.4 Million
Q4 2017 Feb 14, 2018	SELL	$47.53 - $53.73 $9.61 Million - $10.9 Million	-202,242 Reduced 26.34%	565,555 $30.4 Million
Q3 2017 Nov 13, 2017	SELL	$41.15 - $49.22 $6.47 Million - $7.74 Million	-157,265 Reduced 17.0%	767,797 $37 Million
Q2 2017 Aug 14, 2017	BUY	N/A	925,062	925,062 $39.7 Million

Others Institutions Holding NVO

# of Institutions

1,884

Shares Held

336M

Call Options Held

11.9M

Put Options Held

10.6M

View Full List

About NOVO NORDISK A S

Ticker NVO
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 2,257,289,984
Market Cap $205B
Description
Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...

More about NVO

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raymond James & Associates, based on Form 13F filings with the SEC.

News

Stay updated on Raymond James & Associates with notifications on news.

Account

Raymond James & Associates Novo Nordisk A S Transaction History